Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Transdermal Skin Patches Market Growth in 2025?

The market size for transdermal skin patches has been steadily increasing over the past few years. The projected growth is from $7.46 billion in 2024 to $7.72 billion in 2025, revealing a compound annual growth rate (CAGR) of 3.5%. Reasons for this rise in the historic period include a heightened occurrence of cardiovascular diseases, robust economic expansion in developing markets, a hike in pharmaceutical research and development spending, as well as higher healthcare expenditure.

What Is the Forecast for the Transdermal Skin Patches Market Size Through 2029?

The market size for transdermal skin patches is set to witness consistent growth over the next several years, with predictions suggesting a rise to $9.36 billion by 2029, reflecting an average annual growth rate (CAGR) of 4.9%. This growth trajectory during the projected period can be credited to the rise in smoking cessation, the swift increase in the elderly population, escalating healthcare expenditure, and the growing incidence of cardiovascular diseases. Key trends that are expected to shape this sector in the forecast period include advancements in the technology of transdermal skin patches, progress in the development of diabetes transdermal patches, strong research and development initiatives, innovative products, collaborations and strategic partnerships, the rise of wearable skin patches, advancements in microneedle patches for vaccinations and the innovative iontophoresis patches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

What are the Key Market Players in Transdermal Skin Patches Market and How They’re Evolving?

Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy’s Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Łomża Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.

What Are the Primary Growth Drivers in the Transdermal Skin Patches Market?

The rising incidence of heart and blood vessel related diseases is anticipated to stimulate the expansion of the transdermal skin patch market. Such heart-related afflictions are often associated with atherosclerosis, a condition characterized by fatty deposits within arteries, and an elevated risk of blood clot formation. Transdermal skin patches serve to prevent angina, or chest pain, in individuals diagnosed with coronary artery disease, which is characterized by the contraction of blood vessels providing the heart with blood. These patches are additionally utilized to augment bioavailability in treating heart failure. A report released by the American College of Cardiology in August 2022 predicted that within the United States, all four cardiovascular risk factors will see a rise between 2025 and 2060. Anticipated increases include a 39.3% rise in diabetes (equating to 55 million people affected), dyslipidemia increasing by 27.6% to 126 million, hypertension rising by 25.1% to 162 million, and obesity increasing by 18.3% to 126 million. The forecast also noted a significant spike in stroke rates (33.8% or 15 million individuals), heart failure (33.4% or 13 million individuals), followed by ischemic heart disease (30.7% or 29 million people), and heart attacks (16.9% or 16 million people). These projections thus highlight that the escalating incidence of heart disease is fostering the expansion of the transdermal skin patches market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2829&type=smp

What Are the Leading Segments in the Global Transdermal Skin Patches Industry?

The transdermal skin patches market covered in this report is segmented –

1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor

2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types

3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications

Subsegments:

1) By Matrix: Drug-in-matrix Patches, Polymer Matrix Patches

2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer

3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug, Multi-layer Reservoir Patches

4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form, Transdermal Patches Utilizing Vaporization Technology

What Are the Key Market Trends in the Transdermal Skin Patches Industry?

Leading organizations within the transdermal skin patches industry are focusing their attention on developing novel products and securing their approval, in an effort to outshine their competition. This means they strive to deliver innovative solutions, such as medical devices, drugs, or other commodities, that cater to existing issues or demands. For example, in March 2022, Noven Pharmaceuticals Inc., a U.S.-based pharmaceutical firm, secured the approval of the U.S. Food and Drug Administration (FDA) for their XELSTRY (dextroamphetamine) transdermal system. It is a first-of-its-kind amphetamine patch designed for treating ADHD (Attention-Deficit or Hyperactivity Disorder). The user should apply XELSTRYM two hours prior to expecting the desired effect and remove it nine hours after application. The precise dosage should be customized based on the clinical response and levels of tolerance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

What Is the Regional Outlook for the Transdermal Skin Patches Market?

North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2829

This Report Delivers Insight On:

1. How big is the transdermal skin patches market, and how is it changing globally?

2. Who are the major companies in the transdermal skin patches market, and how are they performing?

3. What are the key opportunities and risks in the transdermal skin patches market right now?

4. Which products or customer segments are growing the most in the transdermal skin patches market?

5. What factors are helping or slowing down the growth of the transdermal skin patches market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model